Drug · DIN 02474255
HUMIRA
PREFILLED SYRINGE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since March 26, 2018.
- Drug Identification Number (DIN)
- 02474255
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Adalimumab L04AB04
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ADALIMUMAB | 10 MG | 0.1 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 26, 2018: NOC 20661Supplement to a New Drug Submission (SNDS) · New presentation
Other DINs named HUMIRA
- DIN 02258595 · Marketed
- DIN 02458349 · Marketed
- DIN 02458357 · Marketed
- DIN 02474263 · Marketed
- DIN 02466872 · Approved
- DIN 02474220 · Approved